My clinical and research focus is cystic fibrosis. My research interests are developing new therapies, characterizing and treating early lung disease, and reducing outcomes disparities by identifying and treating children who are at higher risk for adverse outcomes. I am active in healthcare quality improvement at the practice and national level. Since newborn screening in cystic fibrosis has been established in the United States, I have been especially interested in refining care of the newly diagnosed infant and their family, and in bringing highly effective therapies into the care of infants. On the other end of the spectrum of pediatrics, I am engaged in research and program development in transition from pediatric to adult health care environments.

My major academic focus is therapeutic clinical trials. I also evaluate risk factors and health care system processes that contribute to disparate outcomes in cystic fibrosis. In my research leadership role, I enable trials in childhood-onset conditions.

I specialize in pediatric lung disease, focusing on diagnosis and treatment of children with cystic fibrosis.